Credit Suisse Starts Kite Pharma (KITE) at Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
Go back to Credit Suisse Starts Kite Pharma (KITE) at Outperform
July 15, 2014 7:45 AM EDT
Cowen initiated coverage on Kite Pharma (NASDAQ: KITE) with an Outperform rating.
For an analyst ratings summary and ratings history on Kite Pharma click here. For more ratings news on Kite Pharma click here.
Shares of Kite Pharma closed at $24.05 yesterday.
...
More
July 15, 2014 7:44 AM EDT
Stifel Nicolaus initiated coverage on Kite Pharma (NASDAQ: KITE) with a Buy rating and a price target of $31.00.
For an analyst ratings summary and ratings history on Kite Pharma click here. For more ratings news on Kite Pharma click here.
Shares of Kite Pharma closed at $24.05 yesterday.
...
More
July 15, 2014 6:41 AM EDT
Jefferies initiates coverage on Kite Pharma (NASDAQ: KITE) with a Buy rating and a price target of $35.00.
Analyst Biren Amin comments, "KITE shares hold significant promise based on PI/II data with KTE-C19 observing robust responses in... More
